Beleaguered biotechnology company Chiron Corp., still smarting from two high-profile failures to deliver flu vaccines in the United States and Europe, essentially broke even in the second quarter and ...
, the company that's been struggling to get sales of its flu vaccine back up and running, issued third-quarter financial results Tuesday that missed Wall Street's estimates by a wide margin. Before ...
Chiron Corp., the company responsible for last year’s flu vaccine shortage, said Friday that it would not ship 8 million doses slated for non-U.S. markets because of another bacterial contamination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback